We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

Doctors have begun noticing a trend: they all seem to get full before finishing dinner, and it's likely thanks to drugs like ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

The luster is starting to wear off GLP-1 weight-loss drugs including Wegovy and Ozempic as more clinicians warn patients ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...